AGAP12P

Across TCGA pan-cancer cohorts, AGAP12P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated AGAP12P data layer compared with 21 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher AGAP12P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated AGAP12P expression acts as an unfavorable survival marker.

LUAD and SKCM are the cancer types where AGAP12P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.266	0.835	.001	18	view →
SKCM	DFS	Median	III,IV	0.087	0.647	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

AGAP12P–LUAD (OS)

Open the LUAD breakdown →